Dan Mannix

SVP, Regulatory Affairs at IO Biotech

No bio yet

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


IO Biotech

2 followers

IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.


Industries

Employees

11-50

Links